Innate effector cells in angiogenesis and lymphangiogenesis

Area of Science:

• Molecular Biology
• Immunology
• Cell Biology

Background:

• Angiogenesis and lymphangiogenesis are critical processes regulated by complex signaling pathways.
• These processes are active in tumor growth, tissue repair, and chronic inflammation.
• Vascular Endothelial Growth Factors (VEGFs) and Angiopoietins (ANGPTs) are key signaling molecules.

Purpose of the Study:

• To explore the role of immune cells in regulating angiogenesis and lymphangiogenesis.
• To identify immune cells as potential therapeutic targets for inflammatory disorders and tumors.

Main Methods:

• Review of signaling pathways involved in angiogenesis and lymphangiogenesis.
• Analysis of the sources and targets of angiogenic/lymphangiogenic mediators, focusing on immune cells.
• Examination of the role of VEGFs and ANGPTs in activating endothelial cell receptors.

Main Results:

• Immune cells, including macrophages, mast cells, and neutrophils, are significant sources of pro-angiogenic and lymphangiogenic factors.
• These immune cells also express receptors for angiogenic mediators and can be targets of these signals.
• Some immune cells can release anti-angiogenic factors, highlighting a dual role.

Conclusions:

• Immune cells are crucial regulators of both angiogenesis and lymphangiogenesis.
• Targeting immune cells offers a promising therapeutic strategy for managing angiogenesis/lymphangiogenesis in diseases.
• Further research into immune cell manipulation could lead to novel treatments for chronic inflammation and cancer.